Oregon Health and Science University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oregon Health and Science University sits in the top decile of US sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count).
Oregon Health and Science University: 546 sponsored US clinical trials, 91 recruiting.
Oregon Health and Science University sponsors 546 registered US clinical trials on ClinicalTrials.gov, 91 of them currently recruiting, and 370 completed. 73 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Oregon Health and Science University ranks in the top decile of sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
370 of 420 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
546 total, page 7 of 11
Behavioral Interventions to Target Self-Control
NCT02281942
Ambient Independence Measures for Guiding Care Transitions
NCT02566239
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
NCT02070692
Novel Measure of Social Deficits in Children
NCT02035176
Physical Activity and Obesity
NCT02060240
Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)
NCT02279199
Optical Coherence Tomography (OCT) in Retinal Vasculitis
NCT01998464
OCT in Retinal Vein Occlusions
NCT01992575
Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin
NCT01977937
Quantifying the Influence of Expert Modeling
NCT02100215
Preterm Infant Inhaled Albuterol Dosing
NCT02447250
Proprioception Testing in Persons With Sensorimotor Impairment
NCT01974635
Partnering With Autistic Adults to Improve Healthcare
NCT01579669
Assessment of Limb Perfusion During Junctional Tourniquet
NCT02092415
LV Dysfunction Following Pacemaker Placement
NCT03850808
Diffuse Myocardial Fibrosis in Fontan Patients
NCT01929174
Gait Analysis in MPS IVA
NCT01920828
Diabetes PRP and OCT
NCT01928550
Obesity and Oral Contraceptive Failure
NCT01944306
OCT-guided LALAK for KCN
NCT01901614
DBS for Home Monitoring in Children With Kidney Transplantation
NCT01931397
Methylphenidate to Improve Balance and Walking in MS
NCT01896700
Acute Management of Humeral Shaft Fractures: Sling vs. Splint
NCT01869322
Bicuspid Valve Aortopathy Feasibility Study
NCT01920815
Strength and Balance in Gender- and Age-Matched Controls
NCT02110875
Pilot Study of OCT Versus Fluorescein Angiography in DME
NCT01876914
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
NCT01822132
STorz Against Glidescope Effectiveness
NCT01632683
Moderate Intensity Exercise and Phenylketonuria
NCT01904708
Study for the Employment Retention of Veterans
NCT03085953
Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention
NCT01780974
Evaluation of Oral Midazolam in First-trimester Surgical Abortions
NCT01830881
Pilot Study of Free From Falls Program in Multiple Sclerosis
NCT01829776
Examining Bladder Control Using Mindful Based Approach
NCT01843543
Health Protection & Promotion for Oregon Correctional Officers
NCT02098603
Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments
NCT01964664
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function
NCT01723696
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
NCT01807325
Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus
NCT01748305
Stroke Therapy, Education, Prevention: Telemedicine Outpatient Initiative Trial
NCT01875328
The OHSU Pregnancy Exercise & Nutrition (PEN) Program
NCT01719406
Low-dose Propofol for Pediatric Migraine
NCT01604785
Neovascular Age-related Macular Degeneration
NCT01712035
Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia
NCT03842605
Non-exudative Age-related Macular Degeneration
NCT01712841
Quantification of Balance in Acutely Concussed Athletes
NCT01661075
Developmental Origins of Attention Deficit Hyperactivity Disorder
NCT01982422
Fludrocortisone for Sudden Hearing Loss
NCT01186185
Renal Retention of Microbubbles
NCT01647464
Fortified Skimmed Mother's Milk in the Management of Chylothorax
NCT01673165
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 52 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Oregon Health and Science University pipeline
91 recruiting of 546 indexed (17% open); 370 completed (68%).
Phase mix: 73 late (III/IV) vs 92 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oregon Health and Science University: open-pipeline peers nationwide
Peers matched on 546 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Oregon Health and Science University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 546 trials (± recruiting share)
- Ohio State University · 552 trials · 21% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Oregon Health and Science University page
546 registered trials is a research-attention snapshot, not an endorsement of Oregon Health and Science University or any single study.
- 91 of Oregon Health and Science University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Oregon Health and Science University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Oregon Health and Science University pipeline card: 546 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.